Computational Analysis of Genomic Abnormalities from a Phase 3 Trial of Rigosertib in Higher-Risk MDS: Simulation of a Predictive Signature for Clinical Response
暂无分享,去创建一个
B. Brownstein | G. Garcia-Manero | H. Loferer | N. Azarnia | S. Fruchtman | L. Silverman | T. Abbasi | S. Vali | N. Singh | M. Petrone | S. Usmani | H. Grover | Shahabuddin Usmani